Price
$16.48-32.57%Social Signal Score
Analyst Ratings
7 analystsRevenue
$430.81M+66.13%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Erin N. Kane
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 1,410
- Beta
- 1.26
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 1.74
Financials
Revenue
$430.81M+66.1%Net Income
$-7.55MEBITDA
$-7.10MFree Cash Flow
$29.69M+47.5%EPS (diluted)
$-0.28Shares Outstanding (diluted)
27.08M-11.2%Operating Expenses
$19.20MCash & Debt
$22.55MReturn of Capital
$4.36MRevenue by Segment (annual)
$958.54MDividend per Share
$0.16Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.52B | $49.29M | $1.83 |
| 2024 | $1.52B | $44.15M | $1.65 |
| 2023 | $1.53B | $54.62M | $2.00 |
| 2022 | $1.95B | $171.89M | $6.15 |
| 2021 | $1.68B | $139.79M | $4.97 |
| 2020 | $1.16B | $46.08M | $1.64 |
| 2019 | $1.30B | $41.35M | $1.47 |
| 2018 | $1.51B | $66.24M | $2.20 |
| 2017 | $1.48B | $146.70M | $4.81 |
| 2016 | $1.19B | $34.15M | $1.12 |
| 2015 | $1.33B | $63.78M | $2.08 |
| 2014 | $1.79B | $83.86M | $2.74 |
| 2013 | $1.77B | $118.75M | $3.81 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ASIX's reported EPS growth of -5.9% a year over 12 years.
- EPS in 5 years
- $1.35
- Implied price
- $12.17
- Return from $12.86
- -1.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $6.05 — -53.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 5 | 7 | 9 | 11 | 13 |
|---|---|---|---|---|---|
| -15.9% | -21.4% | -15.9% | -11.6% | -8.0% | -4.9% |
| -10.9% | -16.7% | -10.9% | -6.4% | -2.5% | 0.8% |
| -5.9% | -12.1% | -6.0% | -1.1% | 2.9% | 6.4% |
| -0.9% | -7.4% | -1.0% | 4.2% | 8.4% | 12.1% |
| 4.1% | -2.7% | 4.0% | 9.4% | 13.9% | 17.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
30-40.00%Social Signal Score
Mentions (7)
- Newsmarketbeat.com·17d ago·Negative
What AdvanSix (ASIX) Said on Its Q3 Earnings Call AdvanSix NYSE: ASIX reported higher third-quarter sales but lower adjusted earnings as raw material costs and reduced production weighed on profitability. The chemical and fertilizer producer also outlined plans for an ammonia expansion supported by proposed federal funding.
View source ↗ - Newsseekingalpha.com·18d ago·Positive
AdvanSix Inc. (ASIX) Q3 2026 Earnings Call Transcript AdvanSix Inc. ( ASIX ) Q3 2026 Earnings Call November 4, 2026 9:30 AM EST Company Participants Adam Kressel - VP of Investor Relations & Treasurer Erin Kane - CEO, President & Director Patrick Day - Senior VP & CFO Conference Call Participants Zhangir Kozhakhmetov Peter Osterland - Truist Securities, Inc., Research Division Presentation Operator Good day, and welcome to the AdvanSix Third Quarter 2026 Earnings Conference Call. [Operator Instr…
View source ↗ - Newsbusinesswire.com·18d ago·Neutral
AdvanSix Announces Third Quarter 2026 Financial Results PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Third Quarter 2026 Financial Results.
View source ↗ - Newszacks.com·19d ago·Neutral
AdvanSix Secures $47.4M USDA Grant to Expand Ammonia Capacity ASIX secures $47.4M in proposed USDA funding for a $98.1M ammonia expansion project to boost domestic fertilizer supply and strengthen manufacturing capacity.
View source ↗ - Newsseekingalpha.com·105d ago·Neutral
AdvanSix: Challenges Persist, My Downgrade Was Correct AdvanSix (ASIX) faces significant short-term headwinds, with a 90% net income drop and negative FCF in 2Q26, driving a >20% share price decline. ASIX's structurally advantageous single-feedstock model is outweighed by weak end-market demand, limited pricing power, and high exposure to cyclical sectors like fertilizers and nylon. I lower my price target to $16/share, reflecting prolonged macro weakness and industry overcapacity; recovery is e
View source ↗ - Newsseekingalpha.com·107d ago·Positive
AdvanSix Inc. (ASIX) Q2 2026 Earnings Call Transcript AdvanSix Inc. (ASIX) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·107d ago·Neutral
AdvanSix Q2 Earnings Call Highlights AdvanSix NYSE: ASIX reported second-quarter 2026 sales of $421 million, up approximately 3% from a year earlier, as higher pricing offset lower volumes across its portfolio. Adjusted EBITDA was $32 million, down $24 million year over year, while adjusted earnings per share declined $1.05 to $0.19.
View source ↗
Earnings
Fri, Feb 19(in 3 months)
Consensus estimate $-0.15 per share
Typical surprise +12.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$-0.24 vs $-0.04miss
- Fri, Aug 7$0.19 vs $0.56miss
- Fri, May 8$-0.50 vs $-0.47miss
- Fri, Feb 20$0.03 vs $-0.06beat
- Fri, Nov 7$0.08 vs $-0.06beat
- Fri, Aug 1$1.24 vs $0.40beat
Estimates and results for ASIX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ASIX officers and directors.
- Bought
- $149k
- Sold
- $1.4m
1 trade
24 trades
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
75 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Thomas Richard Carpersenate · DE · disclosed Dec 1, 2016 (23d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Nov 7, 2016 (35d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Nov 7, 2016 (35d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Nov 7, 2016 (35d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
